Gyre Therapeutics, Inc. (GYRE) Net margin 2017–2025
Gyre Therapeutics, Inc. (GYRE) net profit margin by fiscal year — reported net income divided by reported revenue.
8.5%FY2025 · since FY2017: -2118.0% → 8.5%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 8.5% | -8.4 pp |
| FY2024 | 16.9% | +92.3 pp |
| FY2023 | -75.3% | -79.6 pp |
| FY2022 | 4.2% | +1202.5 pp |
| FY2021 | -1198.3% | -929.8 pp |
| FY2020 | -268.5% | — |
| FY2018 | -500916.7% | -498798.7 pp |
| FY2017 | -2118.0% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice